Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SIR
1301
DELISTED
SELECT INCOME REIT
SIR
| $9.13M | 0.01% |
804,895
-122,395
| -13% | -$1.37M |
|
1302
Artivion
AORT
$1.37B
| $9.12M | 0.01% |
547,900
+20,900
| +4% | +$369K |
|
1303
Douglas Emmett
DEI
$1.98B
| $9.11M | 0.01% |
237,300
+107,400
| +83% | +$4.12M |
|
|
GOGL
1304
DELISTED
Golden Ocean Group
GOGL
| $9.09M | 0.01% |
1,189,110
+1,005,310
| +547% | +$6.29M |
|
|
BRG
1305
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $9.07M | 0.01% |
736,700
+82,800
| +13% | +$1.06M |
|
|
RSYS
1306
DELISTED
Radisys Corp
RSYS
| $9.05M | 0.01% |
2,261,999
-25,000
| -1% | -$103K |
|
1307
Bar Harbor Bankshares
BHB
$681M
| $9.05M | 0.01% |
273,496
+74,896
| +38% | +$2.2M |
|
1308
Rollins
ROL
$17.5B
| $9.04M | 0.01% |
547,594
-295,200
| -35% | -$4.67M |
|
1309
Utah Medical Products
UTMD
$228M
| $9.02M | 0.01% |
144,700
+7,700
| +6% | +$485K |
|
1310
Builders FirstSource
BLDR
$7.95B
| $8.99M | 0.01% |
603,693
+232,893
| +63% | +$3.01M |
|
|
LSXMK
1311
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $8.97M | 0.01% |
+303,685
| New | +$8.57M |
|
|
GOLD
1312
DELISTED
Randgold Resources Ltd
GOLD
| $8.96M | 0.01% |
102,700
-307,755
| -75% | -$26.8M |
|
|
ATRS
1313
DELISTED
Antares Pharma, Inc.
ATRS
| $8.95M | 0.01% |
3,152,569
+293,228
| +10% | +$705K |
|
1314
Methanex
MEOH
$4.2B
| $8.94M | 0.01% |
+190,598
| New | +$9.15M |
|
1315
NVE Corp
NVEC
$574M
| $8.93M | 0.01% |
107,900
+11,800
| +12% | +$915K |
|
1316
Jakks Pacific
JAKK
$294M
| $8.89M | 0.01% |
161,590
+1,160
| +0.7% | +$61.8K |
|
|
GSS
1317
DELISTED
Golden Star Resources Ltd.
GSS
| $8.88M | 0.01% |
2,096,758
-21,199
| -1% | -$91.3K |
|
|
COBZ
1318
DELISTED
CoBiz Financial,Inc
COBZ
| $8.87M | 0.01% |
527,800
+11,600
| +2% | +$198K |
|
|
ZPIN
1319
DELISTED
Zhaopin Limited
ZPIN
| $8.85M | 0.01% |
513,900
+93,300
| +22% | +$1.54M |
|
|
ECOL
1320
DELISTED
US Ecology, Inc.
ECOL
| $8.85M | 0.01% |
188,900
-47,600
| -20% | -$2.38M |
|
1321
Liberty Media Series C
FWONK
$26B
| $8.84M | 0.01% |
+267,859
| New | +$8.26M |
|
|
THR
1322
DELISTED
Thermon Group Holdings
THR
| $8.84M | 0.01% |
424,200
-41,500
| -9% | -$831K |
|
|
ARC
1323
DELISTED
ARC Document Solutions, Inc.
ARC
| $8.83M | 0.01% |
2,559,900
+150,500
| +6% | +$677K |
|
1324
HNI Corp
HNI
$3.55B
| $8.79M | 0.01% |
190,600
+11,500
| +6% | +$554K |
|
|
MCBC
1325
DELISTED
Macatawa Bank Corp
MCBC
| $8.78M | 0.01% |
889,100
+27,400
| +3% | +$274K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.